Summary
This paper describes a statistical analysis of the simultaneous occurrence of 48 human leucocyte antigens (HLAs) in an attempt to predict whether a patient treated with clozapine will develop granulocytopenia or agranulocytosis. Whereas the numerical results show that use of HLAs does not appear to satisfy the intended purpose, emphasis is placed on the statistical methodology recommended for a problem of this type. Other work in this area is critically discussed.
Similar content being viewed by others
References
Abt K. On the identification of the significant independent variables in linear models. Metrika 12: 1–15, 81-96, 1967
Abt K. Planning controlled clinical trials on the basis of Descriptive Data Analysis. Statistics in Medicine 10: 777–795, 1991
Armitage P, Berry G. Statistical methods in medical research. 2nd ed., Blackwell Scientific Publications, Oxford, 1987
Hald A. Statistical tables and formulas. John Wiley Inc., New York, 1952
Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis EJ. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Archives of General Psychiatry 47: 945–948, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abt, K., Gülich, A., Krupp, P. et al. HLA-Associations in Leponex®/Clozaril® (Clozapine)-Induced Granulocytopenia and Agranulocytosis. Drug-Safety 7 (Suppl 1), 10–16 (1992). https://doi.org/10.2165/00002018-199200071-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199200071-00006